DAPK1 and renal carcinoma: Likewise, the results from RTCA, which monitored the migration of cells dynamically, indicated that ectopic expression of DAPK inhibited the migration of both ACHN and 786‐O cells to the lower surface of the chamber, and DAPK siRNA treatment promoted the migration of renal cancer cells (Fig. 4C,D).